J. Bryan McMichael's Insider Trades & SAST Disclosures
J. Bryan McMichael's most recent trade in Coherus Biosciences Inc was a trade of 200,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern J. Bryan McMichael.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Coherus Biosciences Inc | Bryan J. McMichael | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Bryan J. McMichael | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.39 per share. | 20 Jan 2025 | 1,711 | 22,951 (0%) | 0% | 1.4 | 2,378 | Common Stock |
| Coherus Biosciences Inc | Bryan J. McMichael | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Bryan J. McMichael | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | McMichael Bryan J. | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.44 per share. | 20 Jan 2024 | 1,707 | 22,972 (0%) | 0% | 2.4 | 4,165 | Common Stock |
| Coherus Biosciences Inc | Bryan McMichael J. | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.87 per share. | 07 Jan 2024 | 1,707 | 24,679 (0%) | 0% | 2.9 | 4,899 | Common Stock |
| Coherus Biosciences Inc | J. Bryan McMichael | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Bryan J. McMichael | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Bryan J. McMichael | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Bryan J. McMichael | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 12,500 | 26,386 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | Bryan J. McMichael | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.58 per share. | 07 Jan 2023 | 1,699 | 13,886 (0%) | 0% | 9.6 | 16,276 | Common Stock |
| Coherus Biosciences Inc | Bryan J. McMichael | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Bryan J. McMichael | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges